Ossiform enters U.S. partnership with Asimov Ventures

First step into the U.S. market

Ossiform receives investment from New York based venture capital firm, Asimov Ventures, and enters valuable U.S. partnership. The partnership with Asimov Ventures marks the Company’s first step into the U.S. market, looking toward an early commercialization of P3D Bone in the USA.

Asimov Ventures invests in technology, including but not limited to 3D printing, and GP Tyler Benster says: “Ossiform impressed with its next-generation technology for 3D printing bone. Orthopedic implants have been a major engine of growth for additive manufacturing, although today, these implants are largely produced in titanium. Ossiform’s technology uses calcium phosphate, the same mineral as natural bone. Although there are regulatory milestones ahead to prove that this process is safe, we chose Ossiform as the winner of this year’s Additive Manufacturing Strategies’ startup competition given the massive market opportunity as well as benefit to mankind at large for safer bone implants”.

“We are looking forward to initiate this collaboration with Asimov Ventures which aims to advance the Company’s commercialization activities in the U.S.”, said Thea Wulff Olesen, CEO of Ossiform.

The partnership follows Ossiform’s attendance at the third annual Additive Manufacturing Strategies summit in Boston earlier this year, where the Company won the AMS Startup Competition.

Ossiform is grateful for the recognition and validation of the Company and its technology in the USA, which demonstrates a great market potential for the P3D Bone implant.

For further information, please contact:

Thea Wulff Olesen, CEO
Email: two@ossiform.com 

About Ossiform

Ossiform is a Danish MedTech company founded on proprietary technology to 3D print patient-specific, natural, and resorbable bone implants. This enables fast ingrowth on bone tissue, remodeling into real living bone, and results in fewer complications. The technology can also be used for 3D printed R&D products, implants with additives, such as antibiotics or other drugs, and even in industries outside healthcare. Website Ossiform – We Print Bone.

That's why, We Print Bone

Our mission is to provide 3D printed natural bone implants to reduce complications, improve functional & aesthetics outcomes, and obtain faster recovery

Natural bone porosity, optimized for the ingrowth of new bone

The unique structure of the P3D Bone is designed to facilitate the natural forming of new bone.

Remodels into real living bone

The bone-like material and structure facilitate a remodeling of the implant into new vascularized bone.

Patient-matched designed with the patient's uniqueness in mind

The P3D Bone is 3D printed to enable a full restoration of the functionality and appearance of bones. ​

Resorbable material with structural support

P3D Bone eliminates the need to harvest bone as well as the need for permanent and ill-fitting implants.

P3D Bone Void Filler is expected to launch in 2023

Our first 3D printed, resorbable P3D Bone with modifiable dimensions and a bone-like morphology.

P3D Bone Patient Matched is expected to launch in 2024

Our patient-matched  and resorbable P3D Bone based on the patient's own CT/MRI scan data. ​

We Print Bone​™

Contact us here

Contact us for questions, general inquiries, or to request a quote.
We strive to provide you with highest quality service and expertise in medical 3D printing.

Please make sure all required fields are filled out correctly

Do you have questions?

Give us a call or send us an email: info@ossiform.com

We will get back to you as soon as possible.​

logo - hvid u. baggrund

Ossiform ApS - We Print Bone™

​Oslogade 1, 5000 Odense C​, Denmark

CVR. 38838512

  youtube (1)  facebook  linkedin  twitter  instagram